Cross-sectional survey reveals high levels of drug resistance to dolutegravir among adults in Malawi, suggesting urgent need for monitoring.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kalata et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: